Germano Geno J
SEC-identified person · CIK 1424383 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Precision Biosciences INC DTIL | Director | filed 2020–2026 |
| Harmony Biosciences Holdings, Inc. HRMY | Director | filed 2026–2026 |
| Entera Bio Ltd. [ENTX] | Director | filed 2026–2026 |
| Sage Therapeutics, Inc. SAGE | Director | filed 2016–2025 |
| Medicines CO /DE MDCO | Director | filed 2017–2020 |
| Bioverativ Inc. BIVV | Director | filed 2017–2018 |
| Precigen, INC. XON | President | filed 2016–2016 |
| Pfizer INC pfe | Group President | filed 2010–2015 |
| Zoetis Inc. ZTS | Director | filed 2013–2013 |
| Wyeth WYE | Pres.-US Pharm. & Wom. Health. | filed 2008–2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.